top of page
Search

LogicBio Therapeutics Announces Research Collaboration with Daiichi Sankyo

Writer's picture: SBIJI Innovation SBIJI Innovation

- Under the terms of the research collaboration and exclusive option agreement, the companies will initiate a gene editing research program dedicated to the treatment of two early onset indications with high unmet need, leveraging the GeneRide™ platform -


21 views0 comments

Recent Posts

See All

Comentarios


A Member firm of SBI Group, Japan

© 2020 SBI JI Innovation Advisory Ltd. All rights reserved

bottom of page